Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.

Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol (1997) 10.61

E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J (1995) 4.55

N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol (1999) 4.20

Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene (2008) 3.92

Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am J Pathol (2009) 3.09

Alpha-catenin: at the junction of intercellular adhesion and actin dynamics. Nat Rev Mol Cell Biol (2004) 2.79

E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res (2003) 2.61

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell (2015) 2.39

A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell (1996) 2.39

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res (2001) 2.14

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer (1997) 2.02

The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol (2010) 1.96

Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia (2010) 1.76

Expression of wild-type alpha-catenin protein in cells with a mutant alpha-catenin gene restores both growth regulation and tumor suppressor activities. Mol Cell Biol (1997) 1.64

Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J (2004) 1.62

The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients. Br J Cancer (2007) 1.45

Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer (2008) 1.45

Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. Cancer Epidemiol Biomarkers Prev (2009) 1.43

Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am J Pathol (1995) 1.36

Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res (2004) 1.35

Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell Cycle (2011) 1.34

Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer (1995) 1.26

Loss of heterozygosity in lobular carcinoma in situ of the breast. Clin Mol Pathol (1995) 1.21

Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study. J Clin Pathol (1998) 1.15

E-cadherin as a prognostic indicator in primary breast cancer. Br J Cancer (2001) 1.15

Induction of entosis by epithelial cadherin expression. Cell Res (2014) 1.13

Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Am J Pathol (1995) 1.12

The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin. Am J Pathol (1998) 1.12

Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch (1997) 1.12

Regulation of E-cadherin: does hypoxia initiate the metastatic cascade? Mol Pathol (1999) 1.11

Self-organization is a dynamic and lineage-intrinsic property of mammary epithelial cells. Proc Natl Acad Sci U S A (2011) 1.11

Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut (2001) 1.11

Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol (2001) 1.07

Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene. Br J Cancer (2000) 1.07

Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies. Diagn Pathol (2010) 1.06

Adhesion systems in normal breast and in invasive breast carcinoma. Am J Pathol (1995) 1.06

Low frequency of E-cadherin alterations in familial breast cancer. Breast Cancer Res (2001) 1.04

Secretory breast carcinoma with metastatic sentinel lymph node. World J Surg Oncol (2006) 1.02

E-Cadherin as a diagnostic biomarker in breast cancer. N Am J Med Sci (2011) 1.02

Pleomorphic variant of invasive lobular carcinoma of the male breast. Virchows Arch (2005) 1.01

Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential. Clin Exp Metastasis (2008) 1.01

Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. Mol Pathol (1999) 1.00

Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling. Oncogene (2013) 0.99

Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation. Am J Pathol (2002) 0.99

Differential regulation of growth-promoting signalling pathways by E-cadherin. PLoS One (2010) 0.96

Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer. Cell Oncol (Dordr) (2013) 0.96

Stem cell-related markers in primary breast cancers and associated metastatic lesions. Mod Pathol (2012) 0.95

Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. Mol Pathol (2001) 0.92

E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Br J Cancer (1996) 0.91

Illuminating breast cancer invasion: diverse roles for cell-cell interactions. Curr Opin Cell Biol (2014) 0.91

Lobular breast cancer: molecular basis, mouse and cellular models. Breast Cancer Res (2015) 0.91

Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland. Genes Dev (2016) 0.90

Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast. Virchows Arch (2006) 0.89

A surgically induced hypoxic environment causes changes in the metastatic behaviour of tumours in vitro. Clin Exp Metastasis (2006) 0.88

Modeling cell interactions under flow. J Math Biol (2008) 0.87

Molecular genetics of solid tumours: translating research into clinical practice. What we could do now: breast cancer. Mol Pathol (2001) 0.87

Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas. Clin Exp Metastasis (2014) 0.87

Adhesion in mammary development: novel roles for E-cadherin in individual and collective cell migration. Curr Top Dev Biol (2015) 0.85

E-cadherin expression: a diagnostic utility for differentiating breast carcinomas with ductal and lobular morphologies. J Clin Diagn Res (2013) 0.85

A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome. Sci Rep (2015) 0.84

Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth. J Mol Histol (2004) 0.84

E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast. Virchows Arch (1997) 0.84

E-cadherin and β-catenin adhesion proteins correlate positively with connexins in colorectal cancer. Oncol Lett (2014) 0.82

Aberrant E-cadherin staining patterns in invasive mammary carcinoma. World J Surg Oncol (2005) 0.81

Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast. Virchows Arch (2007) 0.80

Ductal barriers in mammary epithelium. Tissue Barriers (2013) 0.80

Peroxiredoxin V: A candidate breast tumor marker of population specificity. Mol Clin Oncol (2013) 0.80

Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact. J Cancer Res Clin Oncol (1997) 0.79

Elevated expression of E-cadherin in primary breast cancer and its corresponding metastatic lymph node. Int J Clin Exp Med (2015) 0.79

Expression of E-Cadherin in breast carcinomas and its association with other biological markers - a prospective study. Indian J Surg Oncol (2010) 0.79

Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17. Breast Cancer (Auckl) (2010) 0.79

PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma. Cell Rep (2016) 0.78

Loss of CDH1 and Pten accelerates cellular invasiveness and angiogenesis in the mouse uterus. Biol Reprod (2013) 0.78

Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma. Nat Genet (2017) 0.77

Transcription factor Snai1-1 induces osteosarcoma invasion and metastasis by inhibiting E-cadherin expression. Oncol Lett (2014) 0.77

Breast cancer stem cells, pathways and therapeutic perspectives 2011. Indian J Surg (2012) 0.77

Increased incidence of endometrioid tumors caused by aberrations in E-cadherin promoter of mismatch repair-deficient mice. Carcinogenesis (2011) 0.76

The Prognostic Value of E-cadherin Expression in Breast Cancer. Int J Health Sci (Qassim) (2007) 0.76

Loss of Cdh1 and Trp53 in the uterus induces chronic inflammation with modification of tumor microenvironment. Oncogene (2014) 0.76

Prevention of phenytoin-induced gingival overgrowth by lovastatin in mice. Am J Pathol (2015) 0.76

Lobular Breast Cancer in a Male Patient with a Previous History of Irradiation Due to Hodgkin's Disease. Breast Care (Basel) (2012) 0.75

CDH1 germline mutations and hereditary lobular breast cancer. Fam Cancer (2016) 0.75

Lobular carcinoma of the breast with gastrointestinal metastasis. Proc (Bayl Univ Med Cent) (2015) 0.75

Pancreatic solitary and synchronous metastasis from breast cancer: a case report and systematic review of controversies in diagnosis and treatment. World J Surg Oncol (2014) 0.75

Molecular Classification of Lobular Carcinoma of the Breast. Sci Rep (2017) 0.75

EMT: Present and future in clinical oncology. Mol Oncol (2017) 0.75

Cell adhesion heterogeneity reinforces tumour cell dissemination: novel insights from a mathematical model. Biol Direct (2017) 0.75

DC-CLM, a cadherin-like molecule cloned from human dendritic cells, inhibits growth of breast cancer cells. J Cancer Res Clin Oncol (2003) 0.75

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (1987) 49.88

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (1989) 31.55

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer (1957) 21.59

Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem (1991) 8.81

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell (1991) 8.75

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol (1991) 8.60

Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol (1989) 6.31

Cell-adhesion molecule uvomorulin is localized in the intermediate junctions of adult intestinal epithelial cells. J Cell Biol (1985) 6.09

Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci U S A (1990) 5.83

Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res (1989) 4.34

The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer (1975) 4.12

Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol (1990) 4.05

Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell (1982) 3.54

Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol (1992) 3.43

Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci U S A (1991) 3.27

Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell (1991) 3.21

Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res (1993) 3.05

Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol (1993) 2.74

Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol (1991) 2.71

E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res (1991) 2.67

Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res (1990) 2.57

Expression of E- and P-cadherin in gastric carcinomas. Cancer Res (1991) 2.56

Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res (1992) 2.55

Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci U S A (1990) 2.22

Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst (1991) 2.16

Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 1.90

Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol (1993) 1.83

The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci U S A (1991) 1.74

Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett (1991) 1.73

Somatic mutations and human breast cancer. A status report. Cancer (1992) 1.69

Expression of the cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors. Am J Pathol (1989) 1.63

Cytoskeletal components of lymphoid organs. I. Synthesis of cytokeratins 8 and 18 and desmin in subpopulations of extrafollicular reticulum cells of human lymph nodes, tonsils, and spleen. Differentiation (1987) 1.52

Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch A Pathol Anat Histopathol (1992) 1.35

Regional assignment of the human loci for uvomorulin (UVO) and chymotrypsinogen B (CTRB) with the help of two overlapping deletions on the long arm of chromosome 16. Cytogenet Cell Genet (1989) 1.31

Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid. Br J Cancer (1992) 1.27

Expression of E-cadherin in normal, benign, and malignant tissues of female genital organs. Am J Clin Pathol (1992) 1.10

Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc Natl Acad Sci U S A (1991) 1.08

L-CAM expression in normal, premalignant, and malignant colon mucosa. J Pathol (1992) 1.04

Molecular diversity of cytokeratins: significance for cell and tumor differentiation. Acta Histochem Suppl (1991) 0.96

Steroid/thyroid receptor-like proteins with oncogenic potential: a review. Cancer Res (1990) 0.94

[Special clinical and follow-up aspects of invasive lobular breast cancer]. Geburtshilfe Frauenheilkd (1991) 0.81

Functional interaction of beta-catenin with the transcription factor LEF-1. Nature (1996) 15.88

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol (1991) 8.60

beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell (2001) 8.41

Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science (1998) 8.27

Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res (1996) 6.62

Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol (1989) 6.31

Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol (1993) 5.86

Requirement for beta-catenin in anterior-posterior axis formation in mice. J Cell Biol (2000) 4.36

E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol (1994) 4.34

Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol (1990) 4.05

Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin. J Cell Biol (1985) 3.77

New aspects of Wnt signaling pathways in higher vertebrates. Curr Opin Genet Dev (2001) 3.63

Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol (1993) 3.63

Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature (1996) 3.00

In vivo distribution and turnover of fluorescently labeled actin microinjected into human fibroblasts. Proc Natl Acad Sci U S A (1979) 2.71

Microinjection of fluorescently labeled proteins into living cells with emphasis on cytoskeletal proteins. Int Rev Cytol (1982) 2.70

E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res (1991) 2.67

Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J (1992) 2.65

Cell-cell interaction and polarity of epithelial cells: specific perturbation using a monoclonal antibody. Cell (1983) 2.56

E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res (1993) 2.55

On the mechanism of ATP-induced shape changes in human erythrocyte membranes. II. The role of ATP. J Cell Biol (1977) 2.54

The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol (1993) 2.53

Inhibitory action of transforming growth factor beta on endothelial cells. Proc Natl Acad Sci U S A (1987) 2.50

Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J Cell Biol (2000) 2.48

Stress fiber sarcomeres of fibroblasts are contractile. Cell (1980) 2.45

E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci U S A (1994) 2.35

Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J Cell Biol (1996) 2.27

Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas. Virchows Arch (1998) 2.00

Essential role of Gab1 for signaling by the c-Met receptor in vivo. J Cell Biol (2000) 1.97

V-src kinase shifts the cadherin-based cell adhesion from the strong to the weak state and beta catenin is not required for the shift. J Cell Biol (1995) 1.92

Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J Cell Biol (1995) 1.91

Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol (1995) 1.91

Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem Biophys Res Commun (1986) 1.86

Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol (1997) 1.86

Epithelial-mesenchymal transitions in cancer progression. Acta Anat (Basel) (1996) 1.84

The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci U S A (1991) 1.74

New surface component of fibroblast's focal contacts identified by a monoclonal antibody. Cell (1982) 1.73

A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc Natl Acad Sci U S A (1992) 1.70

Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices. Development (2001) 1.69

Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. Nat Struct Biol (2000) 1.67

Molecular aspects of mesenchymal-epithelial interactions. Annu Rev Cell Biol (1993) 1.63

Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer (1991) 1.61

Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene (1995) 1.61

Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res (2001) 1.60

E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice. Gastroenterology (2000) 1.57

Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis. J Cell Biol (1998) 1.56

Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene (1999) 1.55

Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. J Cell Biol (2001) 1.52

Tumor-suppressor gene products in cell contacts: the cadherin-APC-armadillo connection. Curr Opin Cell Biol (1994) 1.48

Corrugated attachment membrane in WI-38 fibroblasts: alternating fibronectin fibers and actin-containing focal contacts. Proc Natl Acad Sci U S A (1980) 1.43

Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer (1996) 1.40

Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene (1998) 1.38

The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif. Oncogene (2001) 1.34

Mechanisms identified in the transcriptional control of epithelial gene expression. J Biol Chem (1996) 1.29

The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras. J Biol Chem (1994) 1.27

Signaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein CRKL. J Biol Chem (2000) 1.22

Cytoplasmic aspartate aminotransferase: syncatalytic sulfhydryl group modification. J Biol Chem (1973) 1.22

Motogenic and morphogenic activity of epithelial receptor tyrosine kinases. J Cell Biol (1996) 1.16

Cell adhesion in invasion and metastasis. Semin Cell Biol (1992) 1.15

Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells. Proc Natl Acad Sci U S A (1995) 1.13

Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res (1997) 1.10

Molecular characteristics of HGF-SF and its role in cell motility and invasion. EXS (1993) 1.10

Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Curr Biol (1998) 1.10

Control of cell locomotion: perturbation with an antibody directed against specific glycoproteins. Cell (1985) 1.09

Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling. Eur J Cancer (1999) 1.07

Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res (1994) 1.06

Intracellular and extracellular components involved in the formation of ventral surfaces of fibroblasts. Cold Spring Harb Symp Quant Biol (1982) 1.02

Differences of E-cadherin expression levels and patterns in primary and metastatic human lung cancer. Clin Exp Metastasis (1994) 1.02

Localization of the human beta-catenin gene (CTNNB1) to 3p21: a region implicated in tumor development. Genomics (1994) 1.01

Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas. J Clin Endocrinol Metab (1995) 1.00

Negative regulation of Ros receptor tyrosine kinase signaling. An epithelial function of the SH2 domain protein tyrosine phosphatase SHP-1. J Cell Biol (2001) 0.99

Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67. Breast Cancer Res Treat (1991) 0.98

Characterization of the scatter factor/hepatocyte growth factor gene promoter. Positive and negative regulatory elements direct gene expression to mesenchymal cells. J Biol Chem (1995) 0.96

Monoclonal antibodies inhibit the adhesion of mouse B 16 melanoma cells in vitro and block lung metastasis in vivo. Proc Natl Acad Sci U S A (1983) 0.96

The role of E-cadherin and scatter factor in tumor invasion and cell motility. EXS (1991) 0.95

Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met. Am J Respir Cell Mol Biol (1993) 0.94

Analysis of the E-cadherin and P-cadherin promoters in murine keratinocyte cell lines from different stages of mouse skin carcinogenesis. Mol Carcinog (1997) 0.93

Interaction of integral and peripheral membrane proteins: affinity labeling of yeast cytochrome oxidase by modified yeast cytochrome c. Proc Natl Acad Sci U S A (1976) 0.92

Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. Hepatology (1993) 0.92

beta-catenin-dependent and -independent effects of DeltaN-plakoglobin on epidermal growth and differentiation. Mol Cell Biol (2004) 0.92

Reversion of the transformed phenotype of B16 mouse melanoma: involvement of an 83 kd cell surface glycoprotein in specific growth inhibition. Cell (1986) 0.92

Dominant and recessive genes involved in tumor cell invasion. Curr Opin Cell Biol (1991) 0.90

Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma. Gynecol Oncol (1995) 0.90

Plakoglobin is essential for myocardial compliance but dispensable for myofibril insertion into adherens junctions. J Cell Biochem (1999) 0.89

Monoclonal antibodies NORM-1 and NORM-2 induce more normal behavior of tumor cells in vitro and reduce tumor growth in vivo. Cell (1985) 0.88

Muscle G-actin is an inhibitor of ATP-induced erythrocyte ghost shape changes and endocytosis. Biochem Biophys Res Commun (1977) 0.86

E-Cadherin in human brain tumours: loss of immunoreactivity in malignant meningiomas. Virchows Arch (1998) 0.86

Hepatocyte growth factor/scatter factor (HGF/SF) signals via the STAT3/APRF transcription factor in human hepatoma cells and hepatocytes. FEBS Lett (1997) 0.85

ATP-induced endocytosis in human erythrocyte ghosts. Characterization of the process and isolation of the endocytosed vesicles. J Biol Chem (1979) 0.85

Cell-cell adhesion in invasion and metastasis of carcinomas. Cancer Treat Res (1994) 0.85

Transforming growth factor beta as a potent promoter in two-stage BALB/c 3T3 cell transformation. Cancer Res (1988) 0.84

Comparison of human hemoglobin A carrying glutathione as a mixed disulfide with the naturally occurring human hemoglobin A. Biochemistry (1973) 0.84

Monoclonal antibodies which prevent experimental lung metastases. Interference with the adhesion of tumour cells to laminin. FEBS Lett (1984) 0.83

Association between coated vesicles and microtubules. Exp Cell Res (1983) 0.83

Monoclonal antibodies that prevent adhesion of B 16 melanoma cells and reduce metastases in mice: crossreaction with human tumor cells. Proc Natl Acad Sci U S A (1983) 0.83

Attempts to understand metastasis formation. I. Metastasis-related molecules. Introduction. Curr Top Microbiol Immunol (1996) 0.82

Peanut lectin histochemistry of 120 mammary carcinomas and its relation to tumor type, grading, staging, and receptor status. Virchows Arch A Pathol Anat Histopathol (1984) 0.81

Syncatalytic modification of cytoplasmic aspartate aminotransferase: identification of a peptide containing the modified cysteinyl residue. FEBS Lett (1972) 0.81